AVNS Avanos Medical Inc

  1. Stocks
  2. Healthcare
  3. NYSE: AVNS

Price (delayed)

$41.14

Market cap

$1.97B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.57

Enterprise value

$2.11B

Sector: Healthcare
Industry: Medical Devices
Website: https://avanos.com/

Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address ...

Highlights

The EPS has grown by 41% YoY
The net income has increased by 41% YoY
The quick ratio has declined by 35% since the previous quarter and by 21% year-on-year
The gross margin has declined by 10% year-on-year and by 4.7% since the previous quarter

Key stats

What are the main financial stats of AVNS
Market
Shares outstanding
47.97M
Market cap
$1.97B
Enterprise value
$2.11B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.57
Price to sales (P/S)
2.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.95
Earnings
Revenue
$714.8M
EBIT
-$44.9M
EBITDA
-$2M
Free cash flow
-$22.7M
Per share
EPS
-$0.57
Free cash flow per share
-$0.47
Book value per share
$26.27
Revenue per share
$14.94
TBVPS
$14.9
Balance sheet
Total assets
$1.67B
Total liabilities
$416.3M
Debt
$248.8M
Equity
$1.26B
Working capital
$300.9M
Liquidity
Debt to equity
0.2
Current ratio
2.81
Quick ratio
1.32
Net debt/EBITDA
-68.65
Margins
EBITDA margin
-0.3%
Gross margin
52.2%
Net margin
-3.8%
Operating margin
0.8%
Efficiency
Return on assets
-1.6%
Return on equity
-2.1%
Return on invested capital
-6.1%
Return on capital employed
-3%
Return on sales
-6.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AVNS stock price

How has the Avanos Medical stock price performed over time
Intraday
-3.92%
1 week
-4.79%
1 month
-4.1%
1 year
42.5%
YTD
-10.33%
QTD
-5.94%

Financial performance

How have Avanos Medical's revenue and profit performed over time
Revenue
$714.8M
Gross profit
$373.3M
Operating income
$5.8M
Net income
-$27.2M
Gross margin
52.2%
Net margin
-3.8%
The operating income has soared by 117% YoY but it is down by 9% QoQ
Avanos Medical's operating margin has soared by 116% YoY but it has decreased by 11% from the previous quarter
Avanos Medical's net margin has increased by 42% YoY
The net income has increased by 41% YoY

Growth

What is Avanos Medical's growth rate over time

Valuation

What is Avanos Medical stock price valuation
P/E
N/A
P/B
1.57
P/S
2.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.95
The EPS has grown by 41% YoY
AVNS's price to book (P/B) is 21% more than its last 4 quarters average of 1.3
The company's equity fell by 2.6% QoQ
The P/S is 38% lower than the 5-year quarterly average of 4.4 but 20% higher than the last 4 quarters average of 2.3
The revenue is up by 2.5% year-on-year

Efficiency

How efficient is Avanos Medical business performance
The ROE has grown by 42% YoY
The return on assets has increased by 36% year-on-year
AVNS's ROIC is up by 14% YoY
The ROS has grown by 10% YoY

Dividends

What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVNS.

Financial health

How did Avanos Medical financials performed over time
The quick ratio has declined by 35% since the previous quarter and by 21% year-on-year
Avanos Medical's total liabilities has decreased by 22% YoY and by 18% from the previous quarter
Avanos Medical's debt is 80% less than its equity
Avanos Medical's debt has decreased by 24% YoY and by 22% from the previous quarter
The debt to equity has contracted by 23% YoY and by 20% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.